Loading...
Although most menstruating women in the U.S. report cyclical mood changes, perhaps 4% to 7% have symptoms severe enough to constitute the clinical syndrome premenstrual dysphoric disorder (PMDD). SSRIs have proved to be efficacious for treating women with PMDD, and recent studies indicate that, unlike the dosing regimen for major depressive disorder, administration limited to the premenstrual phase may be sufficient for relieving PMDD symptoms. In this partially industry-supported study, researchers compared placebo with continuous or intermittent sertraline and also looked at predictors of treatment response.
Approximately 150 women who had three cycles of documented symptoms and met diagnostic criteria for PMDD or severe premenstrual syndr…